Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

New England Journal of Medicine - Tập 368 Số 8 - Trang 709-718 - 2013
Sam Schulman1,2, Clive Kearon2, Ajay K. Kakkar3, Sebastian Schellong4, David Baanstra5, Anne Mathilde Kvamme6, Jeffrey Friedman7, Aurélien Delluc8, Samuel Z. Goldhaber9
1Department of Hematology, Karolinska University Hospital, Stockholm
2Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada
3Thrombosis Research Institute and University College London, London
4Medical Division 2, Municipal Hospital Friedrichstadt, Dresden, Germany
5Clinical Research, Boehringer Ingelheim, Alkmaar, the Netherlands
6Clinical Research, Boehringer Ingelheim, Asker, Norway
7Boehringer Ingelheim, Ridgefield, CT
8Department of Vascular Pathology, Bellevue Hospital, Saint Etienne, France
9Brigham and Women's Hospital and Harvard Medical School, Boston

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1378/chest.08-0658

10.1001/jama.294.6.706

10.1056/NEJMoa0906598

Schulman S, Kakkar AK, Schellong SM, et al. A randomized trial of dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE-COVER II). Presented at the American Society of Hematology Annual Meeting, San Diego, CA, December 10–13, 2011.

10.1056/NEJM199903253401201

10.1056/NEJMoa035422

10.1056/NEJMoa035029

10.1056/NEJMoa030104

10.1056/NEJMoa1007903

10.1056/NEJMoa064247

10.7326/0003-4819-140-11-200406010-00007

10.1056/NEJMe038112

10.1001/jama.293.6.681

10.1001/jama.296.8.935

Hutten BA, 2000, Cochrane Database Syst Rev, 3, CD001367

10.7326/0003-4819-139-1-200307010-00008

10.1056/NEJM200107193450302

10.1056/NEJM199702063360601

10.1056/NEJMoa0905561

10.1056/NEJMc1007378

10.1161/CIRCULATIONAHA.111.055970

10.1001/archinternmed.2011.1666

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 368 Số 8

709-718

Thông tin tác giả